1. Antimicrobial proanthocyanidin-chitosan composite nanoparticles loaded with gentamicin
- Author
-
Sergio Madrigal-Carballo, Jess D. Reed, Christian G. Krueger, Emilia Alfaro-Viquez, and Daniel Esquivel-Alvarado
- Subjects
inorganic chemicals ,Drug Compounding ,education ,Dispersity ,Nanoparticle ,Microbial Sensitivity Tests ,02 engineering and technology ,Biochemistry ,Chitosan ,03 medical and health sciences ,chemistry.chemical_compound ,Anti-Infective Agents ,Structural Biology ,Agglutination Tests ,Spectroscopy, Fourier Transform Infrared ,medicine ,Zeta potential ,Proanthocyanidins ,Surface charge ,Particle Size ,Molecular Biology ,030304 developmental biology ,Drug Carriers ,0303 health sciences ,Bacteria ,Chemistry ,technology, industry, and agriculture ,General Medicine ,021001 nanoscience & nanotechnology ,Antimicrobial ,Proanthocyanidin ,Thermogravimetry ,Nanoparticles ,Gentamicin ,Gentamicins ,0210 nano-technology ,medicine.drug ,Nuclear chemistry - Abstract
Cranberry proanthocyanidin-chitosan nanoparticles (PAC-CHT NPs) loaded with antibiotic gentamicin (GEN) (PAC-CHT-GEN NPs) were formulated and characterized according to size, polydispersity (PDI), surface charge, morphology, and encapsulation efficiency (EE). PAC-CHT-GEN NPs were evaluated for their ability to agglutinate E. coli, S. aureus, and P. aeruginosa and their bacteriostatic and bactericidal activity. Results indicate that the PAC-CHT-GEN NPs at 0.5:1.0, 1.0:1.0, and 2.0:1.0 weight ratios formed stable nanoparticles with sizes from 242.9 to 277.4 nm, a PDI from 0.344 to 0.391, and a zeta potential from 34.5 to 38.5 mV, and up to 94% EE. Results indicate that PAC-CHT-GEN NPs have the ability to agglutinate E. coli, S. aureus, and P. aeruginosa. Furthermore, PAC-CHT-GEN NPs exhibited greater bactericidal activity than GEN alone. Results suggested PAC-CHT-GEN NPs form stable, round-shaped, and bioactive nanoparticles with the potential to be use in the treatment of bacterial infections.
- Published
- 2020